Upregulated expression and function of the α4β1 integrin in multiple myeloma cells resistant to bortezomib - Sevilla‐Movilla - 2020 - The Journal of Pathology - Wiley Online Library
plus dead) labeled
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics | Molecular Pharmaceutics
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
2-Methoxyestradiol at low dose induces differentiation of myeloma cells
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
A) Ultrastructure of NCI-H929 | Download Scientific Diagram
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Types of Multiple Myeloma | International Myeloma Foundation
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
A novel human multiple myeloma cell line with genetic abnormality of 1q21 gains only and CKS1B overexpression